COVID-19 in the context of autologous hematopoietic stem cell transplantation for a patient with autoimmune disease
- 24 December 2021
- journal article
- letter
- Published by Elsevier BV in Current Research in Translational Medicine
- Vol. 70 (2), 103332
- https://doi.org/10.1016/j.retram.2021.103332
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patientsBlood, 2020
- Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Gremeseet alAnnals Of The Rheumatic Diseases, 2020
- Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysisAnnals Of The Rheumatic Diseases, 2020
- Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow TransplantationBone Marrow Transplantation, 2020
- COVID‐19 in bone marrow transplant recipients: reflecting on a single centre experienceBritish Journal of Haematology, 2020
- COVID-19 outcomes in patients with hematologic diseaseBone Marrow Transplantation, 2020
- COVID and hematology: special considerations regarding patient safety, gold standard therapies and safety for health care professionalsHematology, Transfusion and Cell Therapy, 2020
- Indications de l’autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaquesBulletin du Cancer, 2018
- Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an updateBlood Cancer Journal, 2011
- Climate Change, 2007Water, Air, & Soil Pollution, 2007